A mechanistic study of GSK3228836 with fine needle aspiration (FNA) in participants with Chronic Hepatitis B

Trial Identifier: 212602
Sponsor: GlaxoSmithKline
Collaborator:
Not applicable
Start Date: October 2020
Primary Completion Date: November 2023
Study Completion Date: November 2023
Condition: Hepatitis B

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Canada, ON Toronto, ON, Canada, M5G 2C4
Netherlands ROTTERDAM, Netherlands, 3015 GD
United Kingdom London, United Kingdom, E1 1BB
United States, MA Boston, MA, United States, 02114